A study led by researchers at the University of Pittsburgh and UPMC published in JAMA Network Open, found that vaccination against respiratory syncytial virus (RSV) during pregnancy reduced the risk of hospitalization in ...
Jun 5, 2026
0
8
Many Australians have stopped worrying about respiratory viruses. The pandemic has passed and attention has shifted. COVID no longer dominates the headlines, and influenza is often dismissed as a routine winter illness.
Jun 3, 2026
0
4
Respiratory Syncytial Virus (RSV) is a common childhood disease. Most people catch and recover from it by the age of three. 2022 was different, though. There was a severe and early outbreak of RSV that overwhelmed hospitals.
May 26, 2026
0
5
Respiratory syncytial virus (RSV) is a common respiratory virus that can cause severe breathing complications in babies, especially those younger than 6 months old. While many adults recover quickly from RSV with mild symptoms ...
Researchers have discovered a new method to boost the body's natural ability to fight respiratory viruses, including respiratory syncytial virus (RSV), one of the leading causes of severe lung infections worldwide.
May 19, 2026
0
24
Australia's new respiratory syncytial virus (RSV) immunization program cut hospital admissions for Australia's youngest babies by almost half in its first year, a new major national study has shown.
May 15, 2026
0
5
Respiratory syncytial virus (RSV), mostly infects the lungs, nose, throat, and respiratory tract, and can cause illness ranging from mild cold and fever-like symptoms to severe pneumonia and bronchitis. A recent study has ...
Respiratory syncytial virus (RSV) is a common virus that can cause severe respiratory illness in infants and young children, including lower respiratory tract infections (LRTIs) such as bronchiolitis and pneumonia. It is ...
Apr 17, 2026
0
9
Doctors recommend getting your flu shot annually, since the specific influenza strain it targets varies from year to year. But what if the shot could be more effective while protecting against more strains? Researchers from ...
Apr 15, 2026
0
10
Scientists in China have developed a two-antibody cocktail to treat respiratory syncytial virus, or RSV, that in laboratory studies prevented the virus from developing drug resistance—a persistent problem with current therapies ...
